-
In this paper, the authors performed a pharmacoepidemiologic study on the relationship between azithromycin, a frequently used broad-spectrum macrolide antibiotic, and cardiovascular death. The authors analyzed data from the Tennessee Medicaid program.
-
On 15 May the FDA Center for Biologics Evaluation and Research/Office of Blood Research and Review (CBER/OBRR) granted market clearance to the OraQuick in-home HIV-1/2 antibody test based on the recommendation of the Blood Products Advisory Committee.
-
In this issue: Side effects of finasteride; new ruling on pharmaceutical companies paying generic manufacturers; and FDA actions.
-
Coffee is widely consumed throughout the United States. Some prior studies have associated coffee consumption with increased rates of heart disease, whereas other studies have shown less heart disease in coffee drinkers.
-
In this issue: Side effects of statins; effects of cannabis use; antihypertensives and lip cancer; and FDA actions.
-
These three papers and an accompanying editorial1 in a recent issue of the Journal of Travel Medicine form a mini-symposium on pediatric travel medicine. Each gives a glimpse of problems experienced by children traveling internationally and nicely contributes to the limited literature on this topic.
-
NTDs are a group of infectious diseases that are common among the world's poorest people.
-
Uwanyiligira et al retrospectively analyzed charts of all patients seen at the Travel Clinic of the University Hospital in Lausanne, Switzerland, for rabies post-exposure prophylaxis (PEP) between January 2005 and August 2011.
-
At the June 20, 2012 meeting in Atlanta, Georgia the CDC Advisory Committee on Immunization Practices [ACIP] voted in favor of recommending the addition of 13-valent pneumococcal conjugate vaccine (PCV13) to the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for adults aged 19 and older with immunocompromising conditions.
-
Currently adults aged 60 years and older represent 15%-30% of international travelers.